VEN+IDAC vs IDAC in AML
Guangdong Second Provincial General Hospital
Guangdong Second Provincial General Hospital
Amgen
Roswell Park Cancer Institute
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
Eastern Cooperative Oncology Group
City of Hope Medical Center
PETHEMA Foundation
Institute of Hematology & Blood Diseases Hospital, China
Dana-Farber Cancer Institute
Ruijin Hospital
Nanfang Hospital, Southern Medical University
French Innovative Leukemia Organisation
Assistance Publique - Hôpitaux de Paris
Fred Hutchinson Cancer Center
Baylor College of Medicine
Novartis
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
City of Hope Medical Center
Institute of Hematology & Blood Diseases Hospital, China
National Institutes of Health Clinical Center (CC)
Goethe University
University of Maryland, Baltimore
Stanford University
Tata Memorial Centre
National Institutes of Health Clinical Center (CC)
First Affiliated Hospital of Zhejiang University
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Ruijin Hospital
Ohio State University Comprehensive Cancer Center
Amgen
Merus B.V.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Hospital Universitario Dr. Jose E. Gonzalez
Therapeutic Advances in Childhood Leukemia Consortium
Gruppo Italiano Malattie EMatologiche dell'Adulto
Polish Lymphoma Research Group
Celularity Incorporated
Technische Universität Dresden
Cedars-Sinai Medical Center
Beijing 302 Hospital
Peking University People's Hospital
Gruppo Italiano Malattie EMatologiche dell'Adulto
Ludwig-Maximilians - University of Munich
St. Anna Kinderkrebsforschung
Zhejiang University
Guangdong Provincial People's Hospital
M.D. Anderson Cancer Center
University of Bath